Gwendolyn B Scott1, Susan B Brogly, Daniel Muenz, Alice M Stek, Jennifer S Read. 1. Division of Pediatric Infectious Disease and Immunology University of Miami Miller School of Medicine, Miami, Florida; the Department of Surgery, Queen's University, Kingston, Ontario, Canada; the Department of Biostatistics, University of Michigan, Ann Arbor, Michigan; the Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California; and the Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Abstract
OBJECTIVE: To identify missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus (HIV). METHODS: Data regarding HIV-infected children born between 2002 and 2009 to HIV-infected women enrolled in the U.S. International Maternal Pediatric Adolescent AIDS Clinical Trials prospective cohort study (protocol P1025) were reviewed. The characteristics of the HIV-infected infants and their mothers and the mothers' clinical management are described. RESULTS: Twelve cases of mother-to-child transmission of HIV occurred among 1,857 liveborn neonates, for a prevalence of 0.65 per 100 live births to HIV-infected women (95% confidence interval 0.33-1.13). Four transmissions occurred in utero, three were peripartum transmissions, and the timing of transmission for five neonates was unable to be determined. None were breastfed. Seven women had plasma viral loads greater than 400 copies/mL near delivery. Six women had less than 11 weeks of antiretroviral therapy during pregnancy; three of these women had premature deliveries. One woman received no antiretroviral therapy during pregnancy because she was diagnosed with HIV postpartum. Six had poor to moderate adherence to antiretroviral therapy. Four of the five mothers with viral loads greater than 1,000 copies/mL delivered preterm neonates. There were five women who delivered by cesarean; four were nonelective cesarean deliveries and only one was an elective cesarean delivery for HIV prevention. CONCLUSION: Despite access to high-level care and follow-up, a small proportion of HIV-infected women transmitted the virus to their neonates. This case series provides insight into factors contributing to HIV perinatal transmission and can inform the development of new strategies for prevention of mother-to-child transmission of HIV. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT00028145.
OBJECTIVE: To identify missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus (HIV). METHODS: Data regarding HIV-infectedchildren born between 2002 and 2009 to HIV-infectedwomen enrolled in the U.S. International Maternal Pediatric Adolescent AIDS Clinical Trials prospective cohort study (protocol P1025) were reviewed. The characteristics of the HIV-infectedinfants and their mothers and the mothers' clinical management are described. RESULTS: Twelve cases of mother-to-child transmission of HIV occurred among 1,857 liveborn neonates, for a prevalence of 0.65 per 100 live births to HIV-infectedwomen (95% confidence interval 0.33-1.13). Four transmissions occurred in utero, three were peripartum transmissions, and the timing of transmission for five neonates was unable to be determined. None were breastfed. Seven women had plasma viral loads greater than 400 copies/mL near delivery. Six women had less than 11 weeks of antiretroviral therapy during pregnancy; three of these women had premature deliveries. One woman received no antiretroviral therapy during pregnancy because she was diagnosed with HIV postpartum. Six had poor to moderate adherence to antiretroviral therapy. Four of the five mothers with viral loads greater than 1,000 copies/mL delivered preterm neonates. There were five women who delivered by cesarean; four were nonelective cesarean deliveries and only one was an elective cesarean delivery for HIV prevention. CONCLUSION: Despite access to high-level care and follow-up, a small proportion of HIV-infectedwomen transmitted the virus to their neonates. This case series provides insight into factors contributing to HIV perinatal transmission and can inform the development of new strategies for prevention of mother-to-child transmission of HIV. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT00028145.
Authors: Mary-Margaret Andrews; Deborah S Storm; Carolyn K Burr; Erika Aaron; Mary Jo Hoyt; Anne Statton; Shannon Weber Journal: Public Health Rep Date: 2018-08-10 Impact factor: 2.792
Authors: Elaf H Ahmed; Mayar A Shafei; Leena S Alsubhi; Noora A Zarban; Bashair A Al-Zahrani; Mohammed Shaikhomer Journal: Saudi Med J Date: 2021-09 Impact factor: 1.422
Authors: Ari Bitnun; Terry Lee; Jason Brophy; Lindy M Samson; Fatima Kakkar; Wendy Vaudry; Ben Tan; Deborah M Money; Joel Singer; Laura J Sauvé; Ariane Alimenti Journal: CMAJ Open Date: 2018-05-10
Authors: Lorna Dunning; Jordan A Francke; Divya Mallampati; Rachel L MacLean; Martina Penazzato; Taige Hou; Landon Myer; Elaine J Abrams; Rochelle P Walensky; Valériane Leroy; Kenneth A Freedberg; Andrea Ciaranello Journal: PLoS Med Date: 2017-11-21 Impact factor: 11.069
Authors: Lorna Dunning; Aditya R Gandhi; Martina Penazzato; Djøra I Soeteman; Paul Revill; Simone Frank; Andrew Phillips; Caitlin Dugdale; Elaine Abrams; Milton C Weinstein; Marie-Louise Newell; Intira J Collins; Meg Doherty; Lara Vojnov; Patricia Fassinou Ekouévi; Landon Myer; Angela Mushavi; Kenneth A Freedberg; Andrea L Ciaranello Journal: J Int AIDS Soc Date: 2021-01 Impact factor: 6.707